Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver

Journal of Magnetic Resonance Imaging

Volumn 28, Issue 3, 2008, Pages 755-758

  Marin, Daniele ^a   Catalano, Carlo ^a   Rossi, Massimo ^a   Guerrisi, Antonino ^a   Di Martino, Michele ^a   Berloco, Pasquale ^a   Passariello, Roberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Benign liver tumors; Liver, MR; Liver, MR contrast agents

Indexed keywords

GADOBENATE DIMEGLUMINE; IOMEPROL;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ENHANCEMENT; LIVER LEIOMYOMA; LIVER RESECTION; LIVER TUMOR; LIVER VEIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LEIOMYOMA; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED;

EID: 51449102946     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21519     Document Type: Article

References (15)

1. Ishak KJ, Goodman ZD, Stocsker JT. Benign mesenchymal tumors and pseudotumors. In: Ishak KJ, Goodman ZD, Stocsker JT, editors. Tumours of the liver and intrahepatic bile ducts, 3rd ed. Washington, DC: Armed Forces Institute of Pathology; 2001. p 113-114.
2. Urizono Y, Ko S, Kanehiro H, et al. Primary leiomyoma of the liver: report of a case. Surg Today 2006;36:629-632.
3. Kanazawa N, Izumi N, Tsuchiya K, et al. A case of primary leiomyoma of the liver in a patient without evidence of immunosuppression. Hepatol Res 2002;24:80-88.
4. Mesenas SJ, Ng KY, Raj P, Ho JM, Ng HS. Primary leiomyoma of the liver. Singapore Med J 2000;41:129-131.
5. Reinertson TE, Fortune JB, Peters JC, Pagnotta I, Balint JA. Primary leiomyoma of the liver. A case report and review of the literature. Dig Dis Sci 1992;37:622-627.
6. Beuzen F, Roudie J, Moali I, Maitre S. Barthelemy P, Smadja C. Primary leiomyoma of the liver: a rare benign tumour. Gastroenterol Clin Biol 2004;28:1169-1172.
7. Wachsberg RH, Cho KC, Adekosan A. Two leiomyomas of the liver in an adult with AIDS: CT and MR appearance. J Comput Assist Tomogr 1994;18:156-157.
8. Herzberg AJ, MacDonald JA, Tucker JA, Humphrey PA, Meyers WC. Primary leiomyoma of the liver. Am J Gastroenterol 1990;85: 1642-1645.
9. Hawkins EP, Jordan GL, McGavran MH. Primary leiomyoma of the liver. Successful treatment by lobectomy and presentation of criteria for diagnosis. Am J Surg Pathol 1980;4:301-304.
10. Gandhi SN, Brown MA, Wong JG, Aguirre DA, Sirlin CB. MR contrast agents for liver imaging: what, when, how? Radiographics 2006;26:1621-1636.
11. Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology 2001;218:27-38.
12. Spinazzi A, Lorusso V, Pirovano G, Kirchin M. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 1999;6:282-291.
13. Vilgrain V, Boulos L, Vullierme MP, Denys A, Terris B, Menu Y. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 2000;20:379-397.
14. Grazioli L, Morana G, Federle MP, et al. Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine. Radiology 2001;221:731-739.
15. Petersein J, Spinazzi A, Giovagnoni A, et al. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging - a multicenter phase III clinical study. Radiology 2000;215: 727-736.